Home / Clinical Decision Support & Reference / AI-based support system for skin cancer diagnostics

AI-based support system for skin cancer diagnostics

by German Cancer Research Center (DKFZ) · Based in Germany → — AI-based support system for skin cancer diagnostics explains its decisions.

Dermatology Oncology Pathology

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Overview

The German Cancer Research Center (DKFZ) has developed an AI-based support system for skin cancer diagnostics that provides explanations for its decisions. This system aims to address dermatologists’ distrust of AI algorithms by offering transparent, dermatologist-like explanations based on established diagnostic features related to specific areas of suspicious lesions.

The explainable AI (XAI) system was developed to align with how dermatologists approach melanoma diagnosis. In studies, the use of an AI system, including the XAI, increased diagnostic accuracy in melanoma detection and significantly improved dermatologists’ confidence in their own decisions. The system’s explanations, which often matched the doctors’ own criteria, were key to this increased confidence.

The DKFZ is also working on integrating this AI into digital dermatoscopes through the sKIn project, aiming to bring it to market readiness and widespread use in skin cancer screening. This initiative seeks to enhance melanoma diagnostics for patients, physicians, and the healthcare system.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Explainable AI (XAI) for transparent decision-making
Dermatologist-like explanations based on established diagnostic features
Improved diagnostic confidence for clinicians
Increased diagnostic accuracy in melanoma detection
Integration into digital dermatoscopes (in progress)
Reduces cognitive stress and fatigue for dermatologists in challenging cases
Supports endurance in difficult cases in clinical practice

Use Cases

Assisting dermatologists in diagnosing melanoma and other skin tumors
Improving diagnostic accuracy in early-stage melanoma detection
Enhancing physician confidence in AI-supported diagnoses
Integrating AI into skin cancer screening examinations
Reducing cognitive effort for dermatologists when assessing challenging cases

What Physicians Need to Know

Evidence Base (guidelines, literature scope)

The AI-based support system for skin cancer diagnostics, such as DermaSensor, utilizes Elastic Scattering Spectroscopy (ESS) and AI to analyze suspicious skin lesions. This technology is designed to assist in the detection of melanoma, basal cell carcinoma, and squamous cell carcinoma. The system provides objective data to support clinical evaluation alongside visual examination.

Clinical Validation Studies

DermaSensor's AI algorithm has been validated through various prospective clinical studies. It is the first and only FDA-cleared device that uses AI-driven technology to assist physicians in evaluating lesions suggestive of the three common skin cancers. The FDA approval was based on data from the blinded validation DERM-SUCCESS study (NCT05126173), which included 1,579 lesions biopsied in 1,005 patients, and the supplemental melanoma DERM-ASSESS III validation study. The device demonstrated a sensitivity rate of 95.5% across all skin cancers, improving primary care providers' (PCPs) cancer prediction rates by 12.5% (P < 0.0001). Sensitivity rates were 87.5% for melanoma, 97.8% for basal cell carcinoma, and 98.7% for squamous cell carcinoma. The overall specificity rate was 20.7%. Another study indicated that AI-based decision support may increase the diagnostic accuracy of primary care physicians in differentiating melanomas from other skin lesions, potentially reducing unnecessary excisions of benign lesions.

Alert Fatigue Management

While not explicitly detailed for this specific tool, research indicates that dermatologists can distrust AI algorithms they cannot comprehend. An explainable AI (XAI) system has been developed that provides dermatologist-like explanations based on the characteristics of specific, individual zones of the lesion, which increased doctors' confidence in the machine's decisions and their own diagnoses. This suggests that explainability can be a key factor in mitigating alert fatigue and increasing trust.

Differential Diagnosis Support

The AI system assists in evaluating the risk of suspicious skin lesions and identifying patterns associated with skin cancer, providing objective data to support clinical evaluation. It helps in the detection of melanoma, basal cell carcinoma, and squamous cell carcinoma. The AI does not issue a diagnosis but produces a prioritized output (a ranked list of flagged lesions ordered by risk level) for the dermatologist to review. This allows the clinician to apply their own judgment and make the final decision.

Clinical Workflow Integration

The DermaSensor device is designed to integrate into routine patient visits without disrupting clinical workflow, providing rapid, point-of-care results. It is used across various healthcare settings and specialties, including Primary Care, Health Systems, and Specialty Care. The process involves capturing a high-resolution image of a skin lesion, running it through a deep learning model, and presenting the output as a clinical decision support report, which takes seconds and integrates directly into the clinic's existing workflow.

Decision Audit Trail

For clinical decision support systems, an audit trail is considered non-negotiable, documenting who captured, who reviewed, what changed, and when. This ensures traceability, even if it's not a full enterprise EMR logbook.

Physician Tip

Utilize this AI-based support system as a complementary tool to enhance your clinical judgment, especially in primary care settings where access to dermatology specialists may be limited. The system provides objective analysis and risk stratification, which can improve diagnostic accuracy and confidence in evaluating suspicious lesions. Remember that the AI provides a prioritized output, not a definitive diagnosis; your clinical expertise remains paramount for the final decision and patient management. Pay attention to the explainable AI features if available, as understanding the algorithm's rationale can further build trust and aid in your decision-making. Integrate the device seamlessly into your existing workflow for efficient point-of-care assessments.

The DermaSensor device is designed for seamless integration into routine patient visits and various healthcare settings. It provides rapid, point-of-care results. The system's output, a prioritized list of flagged lesions, can be reviewed by the dermatologist and integrates naturally with dermatology lesion tracking systems for longitudinal patient records. For broader AI-based systems, integration into clinical workflow requires addressing operational challenges and regulatory frameworks. Future integrations may include cloud-native medication management and other cloud-based health system technologies.

At a glance

Visit site

Details

Category	Clinical Decision Support & Reference, Dermatology AI, Oncology AI
Pricing	Unknown — unknown
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	Unknown AI-estimated The information provided does not explicitly state whether the AI-based support system has received FDA clearance. However, the sKIn project aims to bring the system to market readiness, taking into account the European Medical Device Regulation (MDR).
Integrations
EHR	Not specified
Specialties	Dermatology, Oncology, Pathology

What the Web Says

AI-based support systems for skin cancer diagnostics show promise in improving diagnostic accuracy, particularly for non-dermatologists and general practitioners. These systems can act as valuable adjuncts to clinical expertise, potentially reducing unnecessary biopsies and facilitating earlier detection. However, their effectiveness can vary depending on the specific AI model, photographic conditions, and the experience level of the user.

Overall: Mixed

Strengths

Improved diagnostic accuracy for healthcare practitioners, especially non-dermatologists and medical students.
Potential to reduce unnecessary biopsies by increasing specificity in identifying benign lesions.
Can increase clinicians' confidence in their diagnoses, particularly with explainable AI (XAI) systems.
Assists in early detection of skin cancer, which is crucial for successful treatment.
Can help alleviate the burden on specialists and make diagnostics more accessible in areas with a shortage of dermatologists.
Some AI tools have received FDA approval, indicating a level of validated performance.

Limitations

AI systems alone may not match the performance of expert dermatologists in real-world clinical settings.
Lack of transparency in AI decision-making can lead to distrust among dermatologists.
Risk of false positives, potentially leading to increased healthcare visits for benign lesions and emotional distress.
Diagnostic accuracy can be affected by photographic conditions (e.g., angle, lighting) and smartphone models.
Image capture can be unsuccessful in a significant percentage of cases, especially when performed by patients.
Some Reddit users reported inaccurate or inconsistent results from AI skin cancer detection apps.

Based on reviews from: AI improves accuracy of skin cancer diagnoses in Stanford Medicine-led study, AI-based support system for skin cancer diagnostics explains its decisions, My experience and DERM AI : r/Melanoma - Reddit, AI Skin-Cancer Scanner Matches the Pros : r/AIGuild - Reddit, The first AI device that can detect all major skin cancers just received FDA approval - Reddit, Skin Cancer Diagnoses Using AI are Reliable | Clinical Lab Products, AI-Powered Diagnosis of Skin Cancer: A Contemporary Review, Open Challenges and Future Research Directions - PMC, AI in dermatology: a comprehensive review into skin cancer detection - PMC, Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis, Using AI for Melanoma Analysis : r/melahomies - Reddit, Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective - Frontiers, Review Examines Pros and Cons in AI Detection of Skin Cancer | AJMC, AI-based support system for skin cancer diagnostics explains its decisions - bionity.com, AI Support Tool Demonstrates Detection Utility for Melanoma at Primary Care Practices, Experts Outperform AI in Real-World Skin Cancer Detection - EMJ, Dermatologists show highest melanoma diagnostic performance with AI support, Skin cancer detection and identification with photos and AI search engines - Reddit, Artificial intelligence-based smartphone application for skin cancer detection: a prospective diagnostic accuracy study - PubMed, Best Dermatology Software 2026 - Capterra, AI Skin Cancer Apps: Do They Work? - MDEdge, Artificial intelligence-based smartphone application for skin cancer detection: a prospective diagnostic accuracy study | British Journal of Dermatology | Oxford Academic, SkinAura AI Software Pricing, Alternatives & More 2026 | Capterra, Ai skin cancer detection app | SmartVisSolution

Last updated: 2026-09-11

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AI-based support system for skin cancer diagnostics

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

German Cancer Research Center (DKFZ)

AI-based support system for skin cancer diagnostics explains its decisions

Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, aiming to increase dermatologists' trust and confidence in AI-assisted diagnoses. This explainable AI (XAI) system provides dermatologist-like explanations based on specific lesion characteristics.

2024-01

bionity.com

AI-based support system for skin cancer diagnostics explains its decisions

This article highlights the development of an AI-based support system for skin cancer diagnostics by the German Cancer Research Center, which offers explanations for its decisions to improve dermatologists' confidence. The system uses established diagnostic features related to suspicious lesions, and a study showed it increased doctors' confidence in their own diagnoses when using the XAI system.

2024-01

Silicon

AI-based Support for Skin Cancer Diagnostics

The German Cancer Research Center has created an AI-based support system for skin cancer diagnostics that provides explanations for its decisions, addressing the distrust many dermatologists have in incomprehensible algorithms. This explainable AI (XAI) aims to align with how dermatologists view melanoma diagnosis and has shown to improve diagnostic confidence.

2024-01

Gesundheitsindustrie BW

AI-based support system for skin cancer diagnostics explains its decisions

This press release from Gesundheitsindustrie BW details the AI-based support system developed by the German Cancer Research Center for skin cancer diagnostics, emphasizing its ability to explain decisions to overcome dermatologists' distrust. The system utilizes established diagnostic features, leading to increased confidence in both the AI's and the doctors' diagnoses.

2024-01

Helmholtz AI

News - Helmholtz AI

Helmholtz AI reports on the German Cancer Research Center's AI-based support system for skin cancer diagnostics that explains its decisions, aiming to build trust among dermatologists who often distrust incomprehensible algorithms. The article notes that the explanations increased doctors' confidence in the machine's decisions and their own diagnoses.

2024-03

Patrick Sanchez (Photo Gallery, referencing Stanford Medicine)

AI improves accuracy of skin cancer diagnoses in Stanford Medicine

A study led by the Stanford Center for Digital Health found that AI algorithms powered by deep learning improved skin cancer diagnostic accuracy for medical professionals. The AI analyzed a large dataset of skin lesion images and patient data, achieving high accuracy in identifying both cancerous and non-cancerous lesions.

unknown

Gesundheitsindustrie BW

Intelligent immunotherapy u2013 safety ensured

This article mentions the 'AI-based support system for skin cancer diagnostics explains its decisions' with a date of January 17, 2024, indicating ongoing developments and related news in the broader field of AI in healthcare.

2026-02

Gesundheitsindustrie BW

Medical technology - Healthcare industry - Gesundheitsindustrie BW

This page from Gesundheitsindustrie BW lists 'AI-based support system for skin cancer diagnostics explains its decisions' as a relevant news item, highlighting the ongoing integration of AI into medical technology for improved diagnostics.

2024-04

Videos

Product demos, reviews, and walkthroughs for AI-based support system for skin cancer diagnostics.

Loading videos...

View all on YouTube

Frequently Asked Questions

How does an AI-based support system for skin cancer diagnostics integrate into my existing clinical workflow?

AI-based support systems are designed to integrate seamlessly, often through DICOM compatibility or API connections, allowing for image upload and analysis within your current PACS or EMR system. The system typically provides a risk assessment or second opinion that can be reviewed alongside your own findings, without requiring significant changes to your established diagnostic process.

What are the regulatory and compliance standards (e.g., FDA, CE Mark, HIPAA) for these AI systems in skin cancer diagnostics?

These AI systems are typically regulated as medical devices and must adhere to stringent standards such as FDA clearance (in the US) or CE Mark certification (in Europe) for their intended use. Furthermore, they must comply with data privacy regulations like HIPAA to ensure patient data security and confidentiality throughout the diagnostic process.

What are the proven alternatives to AI-based support for skin cancer diagnostics, and how do they compare in terms of accuracy and efficiency?

Traditional alternatives include dermoscopy, excisional biopsy with histopathological examination, and clinical examination by a dermatologist. While biopsy remains the gold standard for definitive diagnosis, AI systems aim to improve the accuracy and efficiency of initial screening and triage, potentially reducing unnecessary biopsies and accelerating the diagnostic pathway compared to visual inspection alone.

What is the typical pricing model for an AI-based skin cancer diagnostic support system, and are there options for smaller practices or pay-per-use?

Pricing models vary, often including subscription-based licenses, per-case fees, or tiered pricing based on usage volume. Many vendors offer flexible options, including plans tailored for smaller practices or pilot programs, and some may have pay-per-use models to accommodate varying caseloads and budgets.

What are the known limitations of AI in skin cancer diagnostics, and how do these systems address potential biases or rare presentations?

Limitations can include a dependence on high-quality input images, potential for misinterpretation of rare or atypical lesions not well-represented in training data, and the inability to replace a definitive histological diagnosis. Advanced systems often incorporate mechanisms for flagging uncertain cases for expert review and continuously update their algorithms with diverse datasets to mitigate biases and improve performance on varied presentations.

How does the AI system handle different skin types and Fitzpatrick classifications, and is its performance consistent across diverse patient populations?

Reputable AI systems are trained on diverse datasets that include a wide range of skin types and Fitzpatrick classifications to ensure robust performance across various patient populations. Vendors typically provide data on the system's performance metrics across different demographic groups, and it's crucial to inquire about the diversity of the training data used to validate the system's efficacy.

What kind of training and ongoing support is provided for physicians and their staff to effectively utilize the AI diagnostic system?

Most providers offer comprehensive training programs, including onboarding sessions, user manuals, and online tutorials, to ensure physicians and their staff can effectively operate the system. Ongoing support typically includes technical assistance, regular software updates, and access to clinical support resources to address any questions or issues that may arise.